SYRE Change in Working Capital
Spyre Therapeutics Inc · Change in Working Capital
SYRE Change in Working Capital
Latest reported-$5.01Mperiod ending
SYRE TTM Change in Working Capital ($26.00K → -$5.01M)
TTM change in working capital
High-resolution chart · PNG
SYRE change in working capital history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -5,011,000 | |
| -5,122,000 | |
| -5,934,000 | |
| 7,129,000 | |
| 11,540,000 | |
| -8,575,000 | |
| -4,534,000 | |
| -17,195,000 | |
| -35,497,000 | |
| -369,000 | |
| -5,206,000 | |
| -4,501,000 | |
| 4,581,000 | |
| -2,458,000 | |
| -5,503,000 | |
| -5,858,000 | |
| -6,494,000 | |
| 963,000 | |
| 1,833,000 | |
| 6,842,000 | |
| 4,848,000 | |
| -1,488,000 | |
| -2,540,000 | |
| -2,203,000 | |
| 2,232,000 | |
| 2,371,000 | |
| 7,104,000 | |
| 9,444,000 | |
| 8,785,000 | |
| 7,581,000 | |
| 7,201,000 | |
| 880,000 | |
| -1,745,000 | |
| -809,000 | |
| -198,000 | |
| 698,000 | |
| 1,017,000 | |
| 1,439,000 | |
| 1,450,000 | |
| 3,295,000 | |
| 2,590,000 | |
| -679,000 | |
| -1,335,000 | |
| -4,040,000 | |
| -2,764,000 | |
| 239,000 | |
| 26,000 |